doiMeroni PL 2016 Prevention  treatment of obstetrical compli- cations in APS is hydroxychloroquine the holy grail we are looking for J Autoimmun 751-5. doiMoulis G Audemard-Verger A Arnaud L Luxembourger C Montastruc F Gaman AM Svenungsson E Ruggeri M Mahevas M Gerfaud-Valentin M Brainsky A Michel M Godeau B Lapeyre-Mestre M Sailler L 2016 Risk of thrombo- sis in patients with primary immune thrombocytopenia and antiphospholipid antibodies a systematic review and meta-analy- sis.

Autoimmun Rev 71 85-93. doiMusset L Allenbach Y Benveniste O Boyer O Bossuyt X Bentow C Phillips J Mammen A Van Damme P Westhovens R Ghirardello A Doria A Choi MY Fritzler MJ Schmeling H Muro Y Garcia-De La Torre I Ortiz-Villalvazo MA Bizzaro N Infantino M Imbastaro T Peng Q Wang G Vencovsky J Klein M Krystufkova O Franceschini F Fredi M Hue S Belmondo T Danko K Mahler M 2016 Anti-HMGCR antibodies as abiomarker for immune-mediated necrotizing myopathies a histo- ry of statins and experience from a large international multi-center study.

J Autoimmun 6959-63. doiKomaki F Komaki Y Micic D Ido A Sakuraba A 2017Rizzi M Lorenzetti R Fischer K Staniek J Janowska I Troilo A Strohmeier V Erlacher M Kunze M Bannert B Kyburz D Voll RE Venhoff N Thiel J 2017 Impact of tofacitinib treatment on human B-cells in vitro and in vivo.

Clin Rev Allergy Immunol 523373-388. doiKalyoncu U Solmaz D Emmungil H Yazici A Kasifoglu T Kimyon G Balkarli A Bes C Ozmen M Alibaz-Oner F Erten S Cagatay Y Cetin GY Yilmaz S Yildiz F Pamuk ON Kucuksahin O Kilic L Yazisiz V Karadag O Koca SS Hayran M Akar S Aksu K Akkoc N Keser G Gonullu E Kisacik B Onat AM Soy M Inanc N Direskeneli H Sayarlioglu M Erken E Turgay M Cefle A Ertenli I Pay S 2016 Response rate of initial conventional treatments disease course and related factors of patients with adult-onset Still's disease data from a large mul- ticenter cohort.

J Autoimmun 74194-200. doi Moroni G Doria A Giglio E Tani C Zen M Strigini F Zaina B Tincani A de Liso F Matinato C Grossi C Gatto M Castellana P Limardo M Meroni PL Messa P Ravani P Mosca M 2016 Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century.

J Autoimmun 72 25-32. doiSeaman A Darrah E Infantino M Meacci F Manfredi M Benucci M Mahler M 2016 Anti-peptidyl-arginine deaminase 3 PAD3 antibodies as a promising marker to measure joint dam- age in patients with rheumatoid arthritis.

Autoimmun Rev 159935. doiKlein M Schmalzing M Almanzar G Benoit S Hamm H Tony HP Goebeler M Prelog M 2016 Contribution of CD8 T cells to inflammatory cytokine production in systemic sclerosis SSc.

J Autoimmun 7494- 105. doiGovoni M Bortoluzzi A Padovan M Silvagni E Borrelli M Donelli F Ceruti S Trotta F 2016 The diagnosis and clinical management of the neuropsychiatric manifestations of lupus.

Clin Rev Allergy Immunol 503 367-376. doiMoroni G Depetri F Ponticelli C 2016 Lupus nephritis when and how often to biopsy and what does it mean J Autoimmun 74 27-40. doiMoroni G Doria A Giglio E Imbasciati E Tani C Zen M Strigini F Zaina B Tincani A Gatto M de Liso F Grossi C Meroni PL Cabiddu G Messa P Ravani P Mosca M 2016 Maternal outcome in pregnant women with lupus nephritis.

J Autoimmun 77116-122. doiAlvarado-Cardenas M Marin-Sanchez A Martinez MA Martinez-Martinez L Pinal-Fernandez I Labrador-Horrillo M Balada E Mundet-Tuduri X Gonzalez-Mera L Casademont J Acebes EM Moreno PJ Juarez C Grau-Junyent JM Pujol- Borrell R Selva-O'Callaghan A 2016 Statin-associated autoim- mune myopathy a distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories.

